MYCN and neuroblastoma: In conclusion, our study indicates that Runx1t1 is essential for MYCN-driven tumorigenesis and has provided insight into the key role of this co-repressor not only in neuroblastoma initiation, but also in the progression of this childhood disease, and has opened avenues for the development of potential additional therapeutic treatment approaches.